“…The MIOL evaluated in this prospective, multicentre study is a diffractive, bifocal Tecnis MIOL (ZKB00, Abbott Medical Optics, Santa Ana, California, USA) with a near addition of +2.75 D on IOL plane. It is based on the Tecnis diffractive platform, an optimised diffractive optic, controlling and minimising the level of monochromatic ocular spherical aberration7 as well as chromatic aberrations 9. Multifocal IOLs using this technology provide compensation for the positive spherical aberration that is usually present in the cornea10 and also induce a low chromatic dispersion that can result in an improvement in contrast sensitivity 5…”